- Home
- NBR vs YDES Comparison
NBR vs YDES Comparison
Compare NBR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NBR | YDES |
|---|---|---|
| Founded | 1952 | 2013 |
| Country | Bermuda | Taiwan |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.2M | 894.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NBR | YDES |
|---|---|---|
| Price | $75.98 | $8.70 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $64.57 | N/A |
| AVG Volume (30 Days) | ★ 386.7K | 20.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.27 | N/A |
| Revenue Next Year | $5.59 | N/A |
| P/E Ratio | $4.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.27 | $7.90 |
| 52 Week High | $82.30 | $25.00 |
Technical Indicators
Market Signals| Indicator | NBR | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 61.22 | 38.08 |
| Support Level | $62.71 | $8.12 |
| Resistance Level | N/A | $13.19 |
| Average True Range (ATR) | 4.11 | 0.73 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 68.12 | 21.24 |
Price Performance
Historical ComparisonAbout NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.